GlassScriptPhysician profile
Meily Machado
NPI 1932780210
$11,604.70
in general payments reported to CMS, 2019-2025
24 companies · $2,412 in 2025
The $2,412 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $102 · 2023: $1,088 · 2024: $8,003 · 2025: $2,412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,855 · Food and Beverage: $5,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,855.16 |
| Food and Beverage | $5,647.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,112.62 | 2023-2025 | Ortholoc 3di, Inbone, Augment Injectable |
| Orthofix Medical, INC. | $3,876.52 | 2024-2025 | Truelok, Physio-Stim |
| Kci USA, INC. | $881.09 | 2023 | Prevena, Prevena Restor Arthroform, V.A.C. Veraflo |
| Paragon 28, INC. | $617.15 | 2024 | Mtp |
| Acera Surgical, INC. | $432.40 | 2024-2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $302.38 | 2022-2025 | Evos, Collagenase Santyl, Grafix Pl |
| Amgen INC. | $217.32 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $189.19 | 2024-2025 | Via Matrix, Affinity, Puraply Wound Matrix |
| Shockwave Medical, INC | $164.49 | 2025 | |
| Royal Biologics, INC. | $135.00 | 2024 | |
| Convatec INC. | $133.97 | 2025 | |
| Penumbra, INC. | $116.05 | 2025 | Penumbra System |
| Kerecis Limited | $86.68 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $74.30 | 2024-2025 | |
| Integra Lifesciences Corporation | $53.64 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $52.40 | 2024-2025 | Cmf |
| Saluda Medical Americas, INC. | $27.27 | 2025 | Evoke |
| Paratek Pharmaceuticals, INC. | $23.59 | 2025 | Nuzyra |
| Solventum Corporation | $22.48 | 2025 | Activ.A.C. |
| Biotissue Holdings INC. | $21.14 | 2023 | |
| Urgo Medical North America, LLC | $18.13 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Mimedx Group, INC. | $18.00 | 2025 | |
| Medtronic, INC. | $14.58 | 2023 | Venaseal |
| Kowa Pharmaceuticals America, INC. | $14.31 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meily Machado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.